EGene Inc., an Irvine-based maker of machines for DNA and RNA analysis that trades on the low-profile Bulletin Board exchange, said Friday it is being bought for $34 million in cash and stock by Qiagen NV, a Netherlands-based diagnostic products maker.
The deal’s been approved by both boards and is expected to be completed in the third quarter.
EGene makes a low-cost bird flu screening test, among other things. The company is led by Ming S. Liu, a former principal scientist at Beckman Coulter Inc. in Fullerton.
